Press Releases Events & Presentations Event Details 38th Congress of the International Union Against Sexually Transmitted Infections (IUSTI)- Europe Oct 9 - Oct 11, 2025 Supporting Materials ABI-5366 - Safety, Pharmacokinetics and Antiviral Activity of ABI-5366, a Novel, Oral, Long-Acting HSV Helicase-Primase Inhibitor in Subjects with Recurrent Genital Herpes: Interim Analysis from a Phase 1b Study 471 KB Shareholder Tools Print Email Alerts RSS News Feeds Search Investors
38th Congress of the International Union Against Sexually Transmitted Infections (IUSTI)- Europe Oct 9 - Oct 11, 2025 Supporting Materials ABI-5366 - Safety, Pharmacokinetics and Antiviral Activity of ABI-5366, a Novel, Oral, Long-Acting HSV Helicase-Primase Inhibitor in Subjects with Recurrent Genital Herpes: Interim Analysis from a Phase 1b Study 471 KB
ABI-5366 - Safety, Pharmacokinetics and Antiviral Activity of ABI-5366, a Novel, Oral, Long-Acting HSV Helicase-Primase Inhibitor in Subjects with Recurrent Genital Herpes: Interim Analysis from a Phase 1b Study 471 KB
